Home » Topics » BioWorld Science

BioWorld Science
RSS

IL-9/ARG1/macrophage axis targeting for the treatment of allergic airway inflammation

Feb. 24, 2022

Identification of novel antifungal and antibacterial compounds

Feb. 24, 2022

ConserV receives funding to advance pan-coronavirus vaccine candidate UNICOR-v

Feb. 24, 2022

Jnana selects JNT-517 as development candidate for phenylketonuria

Feb. 24, 2022

Financing at Plexium supports progression of pipeline of targeted protein degradation therapies

Feb. 24, 2022

v7D, varicella vaccine candidate with promising safety and immunogenicity in nonhuman primates

Feb. 24, 2022

Merck & Co. synthesizes new influenza virus Cap-dependent endonuclease inhibitors

Feb. 24, 2022

Femtogenix discovers new antibody-drug conjugates for cancer

Feb. 24, 2022

Prodrugs of clopidogrel's active metabolite identified by Shanghai Curegene Pharmaceutical

Feb. 24, 2022

Adorx Therapeutics discloses adenosine receptor A2A and/or A2B antagonists

Feb. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...